You are currently viewing a new version of our website. To view the old version click .

Epigenetic Biomarkers

This special issue belongs to the section “Human Genomics and Genetic Diseases“.

Special Issue Information

Dear Colleagues,

Writing our 2014 review in Genes on DNA methylation biomarkers made us both realize that this was a fast-moving field. It stretches from biomarker discovery, through development through to clinical implementation. The vast majority of epigenetic biomarkers, in particular DNA methylation biomarkers, come from the fast progressing area of cancer research. However, there are also advances being made in the field of environmental epigenomics and epigenomics of chronic diseases such as cardiovascular disease and type 2 diabetes. We would like to summarize, in a single issue of Genes, the state of the epigenetic biomarkers field in late 2015 by showcasing the best research from around the world. We are flexible about the length and format of articles (original research or review) and flexible about the particular stage of epigenetic biomarker development, from discovery to the clinic. This also includes applications of innovative and clinical relevant methodologies for epigenetic biomarker detection and measurement. We hope you share our interest in this fascinating area and can join us in this exciting undertaking.

Prof. Dr. Jeffrey Craig
Dr. Thomas Mikeska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


Keywords

  • biomarkers
  • epigenetics
  • DNA methylation
  • histone modifications
  • cancer
  • chronic disease
  • predisposition
  • risk prediction
  • diagnosis
  • prognosis
  • methods

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Genes - ISSN 2073-4425